tm
Seeing Is Believing
tm
Seeing Is Believing
Currently out of the existing stock ratings of Jay Olson, 519 are a BUY (89.48%), 2 are a SELL (0.34%), 59 are a HOLD (10.17%).
Analyst Jay Olson, currently employed at OPPENHEIMER, carries an average stock price target met ratio of 44.75% that have a potential upside of 42.04% achieved within 171 days.
Jay Olson’s has documented 1,162 price targets and ratings displayed on 72 stocks. The coverage is on Healthcare, Industrials, Financial Services, Utilities sectors.
Most recent stock forecast was given on SGMT, Sagimet Biosciences Series A Common Stock at 01-Oct-2026.
Analyst best performing recommendations are on NKTR (NEKTAR THERAPEUTICS).
The best stock recommendation documented was for NKTR (NEKTAR THERAPEUTICS) at 11/7/2019. The price target of $300 was fulfilled within 1 day with a profit of $19.5 (6.95%) receiving and performance score of 69.52.
Average potential price target upside
Analyst name
Rating
Current price target
Potential Upside
Previous price target
Date of last PT
Price targets met ratio
Average potential upside
Average Days to Hit Target
Performance score
Buy Since 23-Jun-2025
$36
$16.88 (88.28%)
$37
9 days ago
(08-Oct-2026)
1/10 (10%)
$16.42 (83.86%)
173
Buy Since 15-Dec-2025
$33
$13.88 (72.59%)
$37
22 days ago
(25-Sep-2026)
0/3 (0%)
$12.32 (59.57%)
Buy Since 17-Apr-2025
$34
$14.88 (77.82%)
$36
22 days ago
(25-Sep-2026)
4/6 (66.67%)
$13.32 (64.41%)
144
Buy Since 25-Sep-2025
$31
$11.88 (62.13%)
$38
22 days ago
(25-Sep-2026)
1/4 (25%)
$10.32 (49.90%)
831
Buy Since 28-Feb-2024
$35
$15.88 (83.05%)
$41
22 days ago
(25-Sep-2026)
9/15 (60%)
$14.32 (69.25%)
393
Which stock is Jay Olson most bullish on?
Which stock is Jay Olson most reserved on?
What Year was the first public recommendation made by Jay Olson?
